With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Though a little behind Russia and China, the US pharmaceutical conglomerate Johnson & Johnson has developed a COVID-19 vaccine that elicits a promising antibody response after just one injection...at least in rhesus monkeys. | Mercado, Nature 2020
Comments
Post a Comment